Treatments

Total volatile basic nitogen (mgN/100g) per two weeks

Week 0

Week 2

Week 4

Week 6

Week 8

Control

3.99 ± 0.02^Aa

8.48 ± 0.17^Ab

16.31 ± 0.54^Ac

21.61 ± 0.57^Ad

24.17 ± 0.36^Ae

WH(OG)-EO

2.01 ± 0.02^Ba

2.44 ± 0.06^Ba

5.84 ± 0.16^Bb

9.88 ± 0.51^Bc

12.29 ± 0.23^Bd

MHF(OG)-EO

3.65 ± 0.31^Aa

5.72 ± 0.15^Cb

10.73 ± 0.29^Cc

14.49 ± 0.76^Cd

14.95 ± 0.08^Cd

WH(OB)-EO

3.58 ± 0.05^Aa

7.02 ± 0.23^Db

13.13 ± 0.45^Dc

16.62 ± 0.52^Dd

19.12 ± 0.02^De

MHF(OB)-EO

3.88 ± 0.01^Aa

8.13 ± 0.13^Ab

13.56 ± 0.45^Dc

18.60 ± 0.17^Ed

21.14 ± 0.22^Ee